The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Opus brand of zopiclone Drug Master File in Japan (Opus brand of zopiclone JDMF) empowers Opus brand of zopiclone API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Opus brand of zopiclone JDMF during the approval evaluation for pharmaceutical products. At the time of Opus brand of zopiclone JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Opus brand of zopiclone suppliers with JDMF on PharmaCompass.